Enzyme-linked Immunosorbent Assay Market Players:
- Thermo Fisher Scientific Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Neogen Corporation
- Bio-Rad Laboratories, Inc.
- Merck KGaA
- F. Hoffmann-La Roche Ltd.
- Siemens Healthineers AG
- BD (Becton, Dickinson and Company)
- Agilent Technologies, Inc.
- BioMérieux SA
- Ortho Clinical Diagnostics
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of enzyme-linked immunosorbent assay is evaluated at USD 2.81 billion.
The global enzyme-linked immunosorbent assay market size was worth over USD 2.64 billion in 2025 and is poised to grow at a CAGR of over 7.1%, reaching USD 5.24 billion revenue by 2035.
North America enzyme-linked immunosorbent assay market will hold more than 35% share by 2035, driven by rising prevalence of chronic diseases, increasing healthcare expenditures and focus on early detection.
Key players in the market include Thermo Fisher Scientific Inc., Neogen Corporation, Bio-Rad Laboratories, Inc., Merck KGaA, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, BD (Becton, Dickinson and Company), Agilent Technologies, Inc., BioMérieux SA, Ortho Clinical Diagnostics.
